Low Fat Milk Intake and Cardio Vascular Risk (CVR) Indicators in Children
- Conditions
- Cardiovascular Diseases
- Interventions
- Other: Modification of the content of fat in milkOther: Modification of the content of cows milkOther: Modification of the fat content of cows´ milk
- Registration Number
- NCT01178515
- Lead Sponsor
- Instituto Nacional de Salud Publica, Mexico
- Brief Summary
Substituting whole milk intake for defatted milk will improve indicators of cardiovascular risk, i.e. total cholesterol, triglycerides, Low Density Lipoprotein (LDL) and High Density Lipoprotein (HDL)cholesterol, apolipoproteins: ApoB100, Lp(a) and ApoA in a sample of Mexican children 6-13 years of age.
- Detailed Description
Double blind trial in 600 children 6-13 years of age residing in 12 boarding schools. Schools will be randomized to distribute three types of milk namely: full fat milk (3% fat), partially defatted milk (2% fat) or defatted milk (1% fat) for 90 days of effective exposure (4 months total duration). Subjects will receive 400 mL of the corresponding milk every day (200 mL breakfast and 200 mL night meal) from Monday through Friday. During week ends they will eat a freely chosen diet at home. Milk intake will be measured every day. Diet by 24 h-recall. will be evaluated every month. Blood samples will be obtained at the beginning and at the end of the intervention.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 650
- Attending selected boarding schools
- No lactose intolerance
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Full fat milk Modification of the content of fat in milk Full fat milk contain 3% fat Partially defatted milk Modification of the content of cows milk Partially defatted milk contains 2% of fat Defatted milk Modification of the fat content of cows´ milk Defatted milk contains 1% fat
- Primary Outcome Measures
Name Time Method Cardiovascular risk indicators 4 months Cardiovascular risk is indicated by several determinations of blood fats namely: Total cholesterol, triglicerides, Low-density lipoprotein (LDL) and High density lipoprotein (HDL) cholesterol, lipoproteins: Apo a1,Apo B100 and Lp(a)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Comisíon para el Desarrollo de Pueblos Indigenas
🇲🇽Pachuca, Hidalgo, Mexico